At the same time, more and more evidences have proved that IL-17B/IL-17RB get trapped in the occurrence and poor prognosis of patients with malignant tumors such as pancreatic cancer, gastric cancer, lung cancer and breast cancer (53). Here, IL17RB is linked to lung cancer.